搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
来自MSN
21 小时
Can FDA-approved Journavx Put An End To Death From Opioids?
This approval is considered a major breakthrough in treating acute pain without the need for opioid medication as reliance on ...
5 小时
New non-opioid pain medication approved by FDA
( The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first ...
10 小时
FDA approves Journavx, the first new painkiller in over two decades
The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids.
News Medical on MSN
23 小时
Key information to consider before getting breast implants
Should I get breast implants? Should they be saline or silicone? Which style? How much monitoring is needed after surgery?
15 小时
on MSN
Tree crash paralyzed her, now this device has her tying shoes again
Jessie Owen was severely injured and paralyzed below the shoulders in 2012 when a tree fell on her family’s vehicle as they ...
Daily Jang
10 小时
FDA approves first novel non-opioid painkiller in decades
The US Food and Drug Administration has approved the first-ever non-opioid pain reliever in more than two decades.According ...
Zawya
16 小时
M42 and Hikma sign strategic MOU to enhance preventive and predictive cancer care in the UAE
London – M42, a global health leader powered by artificial intelligence (AI), and Hikma Pharmaceuticals PLC (Hikma), ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈